+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagent & Kits, Analyzers/Instruments), Technology (RIA, ELISA), Application, Specimen, End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 180 Pages
  • December 2023
  • Region: Global
  • Grand View Research
  • ID: 5415506
Description Jump to:
The global immunoassay market size is expected to reach USD 34.47 billion by 2030. The market is expected to expand at a CAGR of 3.60% from 2024 to 2030. The introduction of PoC rapid tests and automated immunoassay analyzers is boosting market growth. In addition, the rising number of chronic and infectious diseases is leading to high market growth.

According to the American Cancer Society, there were an estimated 16.9 million cancer patients/survivors in 2020. Around 1.8 million cancer cases were diagnosed in the U.S., according to the National Cancer Institute 2019 data. According to the American Cancer Society, nearly 606,880 deaths occurred due to cancer in the U.S. in 2019. Thus, the rise in the number of cancer cases being diagnosed is driving the demand for immunoassays. This is expected to boost the market growth in the coming years.

Furthermore, growing awareness regarding infectious diseases and preventive measures has led to a high demand for rapid diagnostic test products, thereby increasing sales. Based on a survey by the WHO on the World malaria report 2018, manufacturers reported sales of 276 million for lateral flow assays in 2017. It also reported that around 75.0% of malaria cases were diagnosed using lateral flow assays in sub-Saharan Africa in 2017.

Several smartphone-based devices and associated tools have emerged as next-generation point-of-care diagnostics or testing devices, thereby boosting the market growth. For instance, a smartphone application combined with the autonomous capillary microfluidic chip is used for the rapid testing of cardiac troponin I in myocardial infarction. This platform can be easily used in resource-limited settings, providing test results within 12 minutes. Thus, novel technological advancements are anticipated to further drive the market over the forecast period.

The first implementation of the Atellica immunoassay solutions with Aptio automation in the United States was announced by Siemens Healthcare GmbH in April 2018. The objective of this product was designed to promote advanced technological products in the U.S. In December 2020, Beckman Coulter, a Danaher business, introduced its first high-quality as well as throughput assay for the COVID-19 antigen detection, officially named Access SARS-CoV-2 Antigen assay. In July 2018, Cygnus Technologies and Gyros Protein Technologies collaborated to produce immunoassay to identify biotherapeutic toxins. The two companies' strategic alliance will primarily focus on offering bioanalytical solutions and increasing biotherapeutics manufacturing efficiencies.

Immunoassay Market Report Highlights

  • The enzyme immunoassays (EIA) segment held the largest market share of 63.39% in 2023, owing to their repeated usage in the detection of infectious and chronic diseases, food allergies, and drug abuse, among other applications.
  • The reagents and kits segment contributed to the largest share of 66.16% in 2023. A significant market share can be attributed to the increased demand for immunoassay reagents and diagnostic kits, owing to the rising prevalence of infectious and autoimmune diseases.
  • Based on application, the infectious diseases testing segment held the largest market share of 36.39% in 2023 and is anticipated to grow at the fastest CAGR over the forecast period.
  • The blood specimen segment held the largest share of 43.11% in 2023 attributed to an increase in disease occurrence, which drives demand for different blood testing procedures, supporting segment growth.
  • Based on end-use, the hospitals segment dominated the market in 2023 with a revenue share of 32.94%. Hospitals and clinics are primary care settings for the diagnosis and treatment of medical conditions.
  • North America generated the highest revenue in 2023 with a 40.60% revenue share. The rise in demand for diagnostics related to chronic diseases and the increase in availability of technologically advanced diagnostic techniques are expected to propel market growth over the forecast period.


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology And Scope
1.1. Market Segmentation
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective - 1
1.2.2. Objective - 2
1.2.3. Objective - 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.3.1. Rising incidence of chronic and infectious diseases
3.3.2. Increasing demand for point-of-care diagnostics
3.3.3. Growing demand for portable and automated immunoassays
3.4. Market Drivers
3.4.1. Lower detection limit
3.4.2. Limitations associated with immunoassay techniques
3.5. Market Restraint Analysis
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Immunoassay market: Product Movement Analysis
4.2. Reagents & Kits
4.2.1. Reagents & Kits Market, 2018-2030 (USD Million)
4.2.2. ELISA Reagents & Kits
4.2.2.1. ELISA Reagents & Kits Market, 2018-2030 (USD Million)
4.2.3. Rapid Test Reagents & Kits
4.2.3.1. Rapid Test Reagents & Kits Market, 2018-2030 (USD Million)
4.2.4. ELISPOT Reagents & Kits
4.2.4.1. ELISPOT Reagents & Kits Market, 2018-2030 (USD Million)
4.2.5. Western Blot Reagents & Kits
4.2.5.1. Western Blot Reagents & Kits Market, 2018-2030 (USD Million)
4.2.6. Other Reagents & Kits
4.2.6.1. Other Reagents & Kits Market, 2018-2030 (USD Million)
4.3. Analyzers/Instruments
4.3.1. Analyzers/Instruments Market, 2018-2030 (USD Million)
4.3.2. Open Ended Systems
4.3.2.1. Open Ended Systems & Kits Market, 2018-2030 (USD Million)
4.3.3. Close Ended Systems
4.3.3.1. Close Ended Systems Reagents & Kits Market, 2018-2030 (USD Million)
4.4. Software & Services
4.4.1. Software & Services Market, 2018-2030 (USD Million)
Chapter 5. Specimen Business Analysis
5.1. Immunoassay Market: Specimen Movement Analysis
5.2. Blood
5.2.1. Blood Market, 2018-2030 (USD Million)
5.3. Saliva
5.3.1. Saliva Market, 2018-2030 (USD Million)
5.4. Urine
5.4.1. Urine Market, 2018-2030 (USD Million)
5.5. Others
5.5.1. Others Market, 2018-2030 (USD Million)
Chapter 6. Technology Business Analysis
6.1. Immunoassay Market: Technology Movement Analysis
6.2. Radioimmunoassay
6.2.1. Radioimmunoassay Market, 2018-2030 (USD Million)
6.3. Enzyme Immunoassays Rapid Test
6.3.1. Enzyme Immunoassays Rapid Test Market, 2018-2030 (USD Million)
6.3.2. Chemiluminescence Immunoassays
6.3.2.1. Chemilluminescence Immunoassays Market, 2018-2030 (USD Million)
6.3.3. Fluroscence Immunoassays
6.3.3.1. Fluroscence Immunoassays Market, 2018-2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018-2030 (USD Million)
Chapter 7. End-use Business Analysis
7.1. Immunoassay Market: Distribution Channel Movement Analysis
7.2. Hospitals
7.2.1. Hospitals Market, 2018-2030 (USD Million)
7.3. Homecare
7.3.1. Homecare Market, 2018-2030 (USD Million)
7.4. Specialty Clinics
7.4.1. Specialty Clinics Market, 2018-2030 (USD Million)
7.5. Others
7.5.1. Others Market, 2018-2030 (USD Million)
Chapter 8. End-use Business Analysis
8.1. Immunoassay Market: Distribution Channel Movement Analysis
8.2. Hospitals
8.2.1. Hospitals Market, 2018-2030 (USD Million)
8.3. Blood Banks
8.3.1. Blood Banks Market, 2018-2030 (USD Million)
8.4. Clinical Laboratories
8.4.1. Clinical Laboratories Market, 2018-2030 (USD Million)
8.5. Pharmaceutical and Biotech Companies
8.5.1. Pharmaceutical and Biotech Companies Market, 2018-2030 (USD Million)
8.6. Academic Research Centers
8.6.1. Academic Research Centers Market, 2018-2030 (USD Million)
8.7. Others
8.7.1. Others Market, 2018-2030 (USD Million)
Chapter 9. Regional Business Analysis
9.1. Immunoassay Market Share By Region, 2023 & 2030
9.2. North America
9.2.1. North America Immunoassay market, 2018-2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Target Disease Prevalence
9.2.2.3. Competitive Scenario
9.2.2.4. Regulatory Framework
9.2.2.5. Reimbursement Scenario
9.2.2.6. U.S. Immunoassay market, 2018-2030 (USD MILLION)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Prevalence
9.2.3.3. Competitive Scenario
9.2.3.4. Regulatory Framework
9.2.3.5. Reimbursement Scenario
9.2.3.6. Canada Immunoassay market, 2018-2030 (USD Million)
9.3. Europe
9.3.1. Europe Immunoassay market, 2018-2030 (USD Million)
9.3.2. Germany
9.3.2.1. Key Country Dynamics
9.3.2.2. Target Disease Prevalence
9.3.2.3. Competitive Scenario
9.3.2.4. Regulatory Framework
9.3.2.5. Reimbursement Scenario
9.3.2.6. Germany Immunoassay market, 2018-2030 (USD Million)
9.3.3. UK
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Competitive Scenario
9.3.3.4. Regulatory Framework
9.3.3.5. Reimbursement Scenario
9.3.3.6. UK Immunoassay market, 2018-2030 (USD Million)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Competitive Scenario
9.3.4.4. Regulatory Framework
9.3.4.5. Reimbursement Scenario
9.3.4.6. France Immunoassay market, 2018-2030 (USD Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Prevalence
9.3.5.3. Competitive Scenario
9.3.5.4. Regulatory Framework
9.3.5.5. Reimbursement Scenario
9.3.5.6. Italy Immunoassay market, 2018-2030 (USD Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Prevalence
9.3.6.3. Competitive Scenario
9.3.6.4. Regulatory Framework
9.3.6.5. Reimbursement Scenario
9.3.6.6. Spain Immunoassay market, 2018-2030 (USD Million)
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Prevalence
9.3.7.3. Competitive Scenario
9.3.7.4. Regulatory Framework
9.3.7.5. Reimbursement Scenario
9.3.7.6. Denmark Immunoassay market, 2018-2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Prevalence
9.3.8.3. Competitive Scenario
9.3.8.4. Regulatory Framework
9.3.8.5. Reimbursement Scenario
9.3.8.6. Sweden Immunoassay market, 2018-2030 (USD Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Prevalence
9.3.9.3. Competitive Scenario
9.3.9.4. Regulatory Framework
9.3.9.5. Reimbursement Scenario
9.3.9.6. Norway Immunoassay market, 2018-2030 (USD Million)
9.4. Asia-Pacific
9.4.1. Asia-Pacific Immunoassay market, 2018-2030 (USD Million)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Target Disease Prevalence
9.4.2.3. Competitive Scenario
9.4.2.4. Regulatory Framework
9.4.2.5. Reimbursement Scenario
9.4.2.6. Japan Immunoassay market, 2018-2030 (USD Million)
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Competitive Scenario
9.4.3.4. Regulatory Framework
9.4.3.5. Reimbursement Scenario
9.4.3.6. China Immunoassay market, 2018-2030 (USD Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Competitive Scenario
9.4.4.4. Regulatory Framework
9.4.4.5. Reimbursement Scenario
9.4.4.6. India Immunoassay market, 2018-2030 (USD Million)
9.4.5. South Korea
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Competitive Scenario
9.4.5.4. Regulatory Framework
9.4.5.5. Reimbursement Scenario
9.4.5.6. South Korea Immunoassay market, 2018-2030 (USD Million)
9.4.6. Australia
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Competitive Scenario
9.4.6.4. Regulatory Framework
9.4.6.5. Reimbursement Scenario
9.4.6.6. Australia Immunoassay market, 2018-2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Competitive Scenario
9.4.7.4. Regulatory Framework
9.4.7.5. Reimbursement Scenario
9.4.7.6. Thailand Immunoassay market, 2018-2030 (USD Million)
9.5. Latin America
9.5.1. Latin America Immunoassay market, 2018-2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Target Disease Prevalence
9.5.2.3. Competitive Scenario
9.5.2.4. Regulatory Framework
9.5.2.5. Reimbursement Scenario
9.5.2.6. Brazil Immunoassay market, 2018-2030 (USD Million)
9.5.3. Mexico
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Competitive Scenario
9.5.3.4. Regulatory Framework
9.5.3.5. Reimbursement Scenario
9.5.3.6. Mexico Immunoassay market, 2018-2030 (USD Million)
9.5.4. Argentina
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Prevalence
9.5.4.3. Competitive Scenario
9.5.4.4. Regulatory Framework
9.5.4.5. Reimbursement Scenario
9.5.4.6. Argentina Immunoassay market, 2018-2030 (USD Million)
9.6. MEA
9.6.1. MEA Immunoassay market, 2018-2030 (USD Million)
9.6.2. South Africa
9.6.2.1. Key Country Dynamics
9.6.2.2. Target Disease Prevalence
9.6.2.3. Competitive Scenario
9.6.2.4. Regulatory Framework
9.6.2.5. Reimbursement Scenario
9.6.2.6. South Africa Immunoassay market, 2018-2030 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Competitive Scenario
9.6.3.4. Regulatory Framework
9.6.3.5. Reimbursement Scenario
9.6.3.6. Saudi Arabia Immunoassay market, 2018-2030 (USD Million)
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Prevalence
9.6.4.3. Competitive Scenario
9.6.4.4. Regulatory Framework
9.6.4.5. Reimbursement Scenario
9.6.4.6. UAE Immunoassay market, 2018-2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Prevalence
9.6.5.3. Competitive Scenario
9.6.5.4. Regulatory Framework
9.6.5.5. Reimbursement Scenario
9.6.5.6. Kuwait Immunoassay market, 2018-2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Participant’s overview
10.2. Financial performance
10.3. Participant categorization
10.3.1. Market Leaders
10.3.2. Immunoassay market Share Analysis, 2023
10.3.3. Company Profiles
10.3.3.1. Siemens Healthineers
10.3.3.1.1. Company Overview
10.3.3.1.2. Financial Performance
10.3.3.1.3. Product Benchmarking
10.3.3.1.4. Strategic Initiatives
10.3.3.2. bioMérieux SA
10.3.3.2.1. Company Overview
10.3.3.2.2. Financial Performance
10.3.3.2.3. Product Benchmarking
10.3.3.2.4. Strategic Initiatives
10.3.3.3. Abbott Laboratories
10.3.3.3.1. Company Overview
10.3.3.3.2. Financial Performance
10.3.3.3.3. Product Benchmarking
10.3.3.3.4. Strategic Initiatives
10.3.3.4. Danaher Corporation (Beckman Coulter)
10.3.3.4.1. Company Overview
10.3.3.4.2. Financial Performance
10.3.3.4.3. Product Benchmarking
10.3.3.4.4. Strategic Initiatives
10.3.3.5. Quidel Corporation
10.3.3.5.1. Company Overview
10.3.3.5.2. Financial Performance
10.3.3.5.3. Product Benchmarking
10.3.3.5.4. Strategic Initiatives
10.3.3.6. Ortho Clinical Diagnostics
10.3.3.6.1. Company Overview
10.3.3.6.2. Financial Performance
10.3.3.6.3. Product Benchmarking
10.3.3.6.4. Sysmex Corporation
10.3.3.7. Bio-Rad Laboratories, Inc.
10.3.3.7.1. Company Overview
10.3.3.7.2. Financial Performance
10.3.3.7.3. Product Benchmarking
10.3.3.7.4. Strategic Initiatives
10.3.3.8. Becton, Dickinson, and Company
10.3.3.8.1. Company Overview
10.3.3.8.2. Financial Performance
10.3.3.8.3. Product Benchmarking
10.3.3.8.4. Strategic Initiatives
10.3.3.9. F. Hoffmann-La Roche AG
10.3.3.9.1. Company Overview
10.3.3.9.2. Financial Performance
10.3.3.9.3. Product Benchmarking
10.3.3.9.4. Strategic Initiatives
10.3.3.10. Thermo Fisher Scientific, Inc
10.3.3.10.1. Company Overview
10.3.3.10.2. Financial Performance
10.3.3.10.3. Product Benchmarking
10.3.3.10.4. Strategic Initiatives
10.3.3.11. Sysmex Corporation
10.3.3.11.1. Company Overview
10.3.3.11.2. Financial Performance
10.3.3.11.3. Product Benchmarking
10.3.3.11.4. Strategic Initiatives
10.3.4. Strategy Mapping
10.3.4.1. Expansion
10.3.4.2. Acquisition
10.3.4.3. Collaborations
10.3.4.4. Disease Type/Drug Class Launch
10.3.4.5. Partnerships
10.3.4.6. Others
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 4 Global Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 5 Global Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 6 Global Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 7 Global Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 8 Global Immunoassays Market, by Region, 2018-2030 (USD Million)
Table 9 North America Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 10 North America Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 11 North America Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 12 North America Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 13 North America Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 14 North America Immunoassays Market, by Country, 2018-2030 (USD Million)
Table 15 U.S. Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 16 U.S. Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 17 U.S. Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 18 U.S. Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 19 U.S. Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 20 Canada Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 21 Canada Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 22 Canada Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 23 Canada Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 24 Canada Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 25 Europe Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 26 Europe Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 27 Europe Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 28 Europe Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 29 Europe Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 30 Europe Immunoassays Market, by Country, 2018-2030 (USD Million)
Table 31 Germany Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 32 Germany Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 33 Germany Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 34 Germany Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 35 Germany Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 36 UK Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 37 UK Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 38 UK Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 39 UK Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 40 UK Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 41 France Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 42 France Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 43 France Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 44 France Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 45 France Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 46 Spain Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 47 Spain Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 48 Spain Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 49 Spain Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 50 Spain Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 51 Italy Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 52 Italy Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 53 Italy Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 54 Italy Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 55 Italy Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 56 Denmark Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 57 Denmark Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 58 Denmark Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 59 Denmark Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 60 Denmark Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 61 Sweden Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 62 Sweden Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 63 Sweden Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 64 Sweden Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 65 Sweden Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 66 Norway Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 67 Norway Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 68 Norway Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 69 Norway Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 70 Norway Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 71 Asia-Pacific Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 72 Asia-Pacific Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 73 Asia-Pacific Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 74 Asia-Pacific Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 75 Asia-Pacific Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 76 Asia-Pacific Immunoassays Market, by Country, 2018-2030 (USD Million)
Table 77 South Korea Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 78 South Korea Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 79 South Korea Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 80 South Korea Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 81 South Korea Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 82 Thailand Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 83 Thailand Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 84 Thailand Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 85 Thailand Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 86 Thailand Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 87 Australia Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 88 Australia Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 89 Australia Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 90 Australia Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 91 Australia Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 92 China Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 93 China Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 94 China Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 95 China Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 96 China Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 97 Japan Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 98 Japan Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 99 Japan Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 100 Japan Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 101 Japan Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 102 India Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 103 India Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 104 India Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 105 India Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 106 India Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 107 Latin America Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 108 Latin America Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 109 Latin America Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 110 Latin America Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 111 Latin America Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 112 Latin America Immunoassays Market, by Country, 2018-2030 (USD Million)
Table 113 Brazil Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 114 Brazil Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 115 Brazil Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 116 Brazil Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 117 Brazil Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 118 Mexico Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 119 Mexico Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 120 Mexico Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 121 Mexico Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 122 Mexico Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 123 Argentina Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 124 Argentina Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 125 Argentina Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 126 Argentina Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 127 Argentina Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 128 Middle East & Africa Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 129 Middle East & Africa Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 130 Middle East & Africa Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 131 Middle East & Africa Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 132 Middle East & Africa Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 133 Middle East & Africa Immunoassays Market, by Country, 2018-2030 (USD Million)
Table 134 South Africa Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 135 South Africa Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 136 South Africa Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 137 South Africa Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 138 South Africa Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 139 Saudi Arabia Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 140 Saudi Arabia Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 141 Saudi Arabia Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 142 Saudi Arabia Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 143 Saudi Arabia Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 144 UAE Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 145 UAE Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 146 UAE Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 147 UAE Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 148 UAE Immunoassays Market, by Specimen, 2018-2030 (USD Million)
Table 149 Kuwait Immunoassays Market, by Product, 2018-2030 (USD Million)
Table 150 Kuwait Immunoassays Market, by Application, 2018-2030 (USD Million)
Table 151 Kuwait Immunoassays Market, by Technology, 2018-2030 (USD Million)
Table 152 Kuwait Immunoassays Market, by End-use, 2018-2030 (USD Million)
Table 153 Kuwait Immunoassays Market, by Specimen, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Immunoassays Market Segmentation
Figure 8 Market Driver Relevance Analysis (Current & Future Impact)
Figure 9 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 10 Market Challenge Relevance Analysis (Current & Future Impact)
Figure 11 Penetration & Growth Prospect Mapping
Figure 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 13 Porter’s Five Forces Analysis
Figure 14 Market Penetration Vs Growth Prospect Mapping, 2023
Figure 15 Regional Marketplace: Key Takeaways
Figure 16 Regional Outlook, 2023 & 2030
Figure 17 North America Immunoassays Market, 2018-2030 (USD Million)
Figure 18 U.S. Immunoassays Market, 2018-2030 (USD Million)
Figure 19 Canada Immunoassays Market, 2018-2030 (USD Million)
Figure 20 Europe Immunoassays Market, 2018-2030 (USD Million)
Figure 21 Germany Immunoassays Market, 2018-2030 (USD Million)
Figure 22 UK Immunoassays Market, 2018-2030 (USD Million)
Figure 23 France Immunoassays Market, 2018-2030 (USD Million)
Figure 24 Spain Immunoassays Market, 2018-2030 (USD Million)
Figure 25 Italy Immunoassays Market, 2018-2030 (USD Million)
Figure 26 Russia Immunoassays Market, 2018-2030 (USD Million)
Figure 27 Asia-Pacific Immunoassays Market, 2018-2030 (USD Million)
Figure 28 Japan Immunoassays Market, 2018-2030 (USD Million)
Figure 29 China Immunoassays Market, 2018-2030 (USD Million)
Figure 30 India Immunoassays Market, 2018-2030 (USD Million)
Figure 31 Australia Immunoassays Market, 2018-2030 (USD Million)
Figure 32 South Korea Immunoassays Market, 2018-2030 (USD Million)
Figure 33 Singapore Immunoassays Market, 2018-2030 (USD Million)
Figure 34 Latin America Immunoassays Market, 2018-2030 (USD Million)
Figure 35 Brazil Immunoassays Market, 2018-2030 (USD Million)
Figure 36 Mexico Immunoassays Market, 2018-2030 (USD Million)
Figure 37 Argentina Immunoassays Market, 2018-2030 (USD Million)
Figure 38 Middle East and Africa Immunoassays Market, 2018-2030 (USD Million)
Figure 39 South Africa Immunoassays Market, 2018-2030 (USD Million)
Figure 40 Saudi Arabia Immunoassays Market, 2018-2030 (USD Million)
Figure 41 UAE Immunoassays Market, 2018-2030 (USD Million)
Figure 42 Global Immunoassays Market, for, Reagents & Kits 2018-2030 (USD Million)
Figure 43 Global Immunoassays Market, for, ELISA Reagents & Kits 2018-2030 (USD Million)
Figure 44 Global Immunoassays Market, for, Rapid Test Reagents & Kits 2018-2030 (USD Million)
Figure 45 Global Immunoassays Market, for, ELISPOT Reagents & Kits 2018-2030 (USD Million)
Figure 46 Global Immunoassays Market, for, Western Blot Reagents & Kits 2018-2030 (USD Million)
Figure 47 Global Immunoassays Market, for, Other Reagents & Kits 2018-2030 (USD Million)
Figure 48 Global Immunoassays Market, for, Analyzers/Instruments 2018-2030 (USD Million)
Figure 49 Global Immunoassays Market, for, Open-ended Systems 2018-2030 (USD Million)
Figure 50 Global Immunoassays Market, for, Closed-ended Systems 2018-2030 (USD Million)
Figure 51 Global Immunoassays Market, for, Software & Services 2018-2030 (USD Million)
Figure 52 Global Immunoassays Market, for, Radioimmunoassay (RIA) 2018-2030 (USD Million)
Figure 53 Global Immunoassays Market, for, Enzyme Immunoassays (EIA) 2018-2030 (USD Million)
Figure 54 Global Immunoassays Market, for, Chemiluminescence Immunoassays (CLIA) 2018-2030 (USD Million)
Figure 55 Global Immunoassays Market, for, Fluorescence Immunoassays (FIA) 2018-2030 (USD Million)
Figure 56 Global Immunoassays Market, for, Rapid Test 2018-2030 (USD Million)
Figure 57 Global Immunoassays Market, for, Others 2018-2030 (USD Million)
Figure 58 Global Immunoassays Market, for, Therapeutic Drug Monitoring 2018-2030 (USD Million)
Figure 59 Global Immunoassays Market, for, Oncology 2018-2030 (USD Million)
Figure 60 Global Immunoassays Market, for, Cardiology 2018-2030 (USD Million)
Figure 61 Global Immunoassays Market, for, Endocrinology 2018-2030 (USD Million)
Figure 62 Global Immunoassays Market, for, Infectious Disease Testing 2018-2030 (USD Million)
Figure 63 Global Immunoassays Market, for, Autoimmune Diseases 2018-2030 (USD Million)
Figure 64 Global Immunoassays Market, for, Others 2018-2030 (USD Million)
Figure 65 Global Immunoassays Market, for, Blood 2018-2030 (USD Million)
Figure 66 Global Immunoassays Market, for, Saliva 2018-2030 (USD Million)
Figure 67 Global Immunoassays Market, for, Urine 2018-2030 (USD Million)
Figure 68 Global Immunoassays Market, for, Other Specimens 2018-2030 (USD Million)
Figure 69 Global Immunoassays Market, for, Hospitals 2018-2030 (USD Million)
Figure 70 Global Immunoassays Market, for, Blood Banks 2018-2030 (USD Million)
Figure 71 Global Immunoassays Market, for, Clinical Laboratories 2018-2030 (USD Million)
Figure 72 Global Immunoassays Market, for, Pharmaceutical and Biotech Companies 2018-2030 (USD Million)
Figure 73 Global Immunoassays Market, for, Academic Research Centers 2018-2030 (USD Million)
Figure 74 Global Immunoassays Market, for, Others 2018-2030 (USD Million)

Companies Mentioned

  • Siemens Healthineers
  • bioMérieux SA
  • Abbott Laboratories
  • Danaher Corporation (Beckman Coulter)
  • Quidel Corporation
  • Ortho Clinical Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson, and Company
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc
  • Sysmex Corporation

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Immunoassay Market by Product (Analyzer, Consumables), Technology (Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Fluoroimmunoassay), Specimen, Indication, End User - Forecast 2024-2030 - Product Image

Global Immunoassay Market by Product (Analyzer, Consumables), Technology (Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Fluoroimmunoassay), Specimen, Indication, End User - Forecast 2024-2030

  • Report
  • 196 Pages
  • Global
From
Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, CLIA, Rapid Tests), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Endocrinology), End User (Hospitals & Clinics, Blood Banks) & Region - Global Forecast to 2028 - Product Image

Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, CLIA, Rapid Tests), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Endocrinology), End User (Hospitals & Clinics, Blood Banks) & Region - Global Forecast to 2028

  • Report
  • 382 Pages
  • Global
From
Global Syphilis Immunoassay Diagnostic Market by Product (Analyzer, Kit & Reagent), Technology (CLIA, ELISA), End User - Forecast 2024-2030 - Product Image

Global Syphilis Immunoassay Diagnostic Market by Product (Analyzer, Kit & Reagent), Technology (CLIA, ELISA), End User - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes) Technology (Immunoassay, Biochemistry, Molecular Diagnostic, Microbiology, Hematology) Use (Clinical, RUO) End User - Global Forecast to 2030 - Product Image

In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes) Technology (Immunoassay, Biochemistry, Molecular Diagnostic, Microbiology, Hematology) Use (Clinical, RUO) End User - Global Forecast to 2030

  • Report
  • 389 Pages
  • Global
From
Microfluidic Immunoassay Market by Product, Technology, Application, and End User - Global Forecast to 2030 - Product Image

Microfluidic Immunoassay Market by Product, Technology, Application, and End User - Global Forecast to 2030

  • Report
  • 269 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.